These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 571748)

  • 21. An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report.
    Hendin HM; Penn AD
    Bipolar Disord; 2021 Nov; 23(7):733-735. PubMed ID: 33934465
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms].
    Lassen JF; Ravn HB; Lassen SF
    Ugeskr Laeger; 1990 Jan; 152(5):314-7. PubMed ID: 2301080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
    Hart WL; Parmley LF
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].
    Jastrzebski M; Bala A
    Psychiatr Pol; 2013; 47(6):1157-67. PubMed ID: 25007546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rising price of mushrooms.
    Young RE; Milroy R; Hutchison S; Kesson CM
    Lancet; 1982 Jan; 1(8265):213-5. PubMed ID: 6119567
    [No Abstract]   [Full Text] [Related]  

  • 27. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
    Ross S; Bossis A; Guss J; Agin-Liebes G; Malone T; Cohen B; Mennenga SE; Belser A; Kalliontzi K; Babb J; Su Z; Corby P; Schmidt BL
    J Psychopharmacol; 2016 Dec; 30(12):1165-1180. PubMed ID: 27909164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hallucinogenic mushrooms in Mississippi.
    Jacobs KW
    J Miss State Med Assoc; 1975 Feb; 16(2):35-7. PubMed ID: 1089159
    [No Abstract]   [Full Text] [Related]  

  • 29. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
    Berkowitz JM
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of psilocybin and psilocin in mushroom extracts by reversed-phase high performance liquid chromatography.
    Thomson BM
    J Forensic Sci; 1980 Oct; 25(4):779-85. PubMed ID: 7191888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?
    Whelan A; Johnson MI
    Pain Manag; 2018 May; 8(3):217-229. PubMed ID: 29722608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New hallucinogenic mushrooms in Norway].
    Høiland K; Christiansen AL; Rasmussen KE
    Tidsskr Nor Laegeforen; 1984 Aug; 104(24):1665-6. PubMed ID: 6540900
    [No Abstract]   [Full Text] [Related]  

  • 33. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
    Stokes DK
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hallucinogenic effect of 2 mushrooms of the genus Psilocybe from Czechoslovakia].
    Auert G; Dolezal V; Hausner M; Semerdzieva M
    Z Arztl Fortbild (Jena); 1980 Sep; 74(17):833-5. PubMed ID: 7192453
    [No Abstract]   [Full Text] [Related]  

  • 35. Lorazepam in the management of anxiety associated with chronic gastrointestinal disease: a double-blind study.
    Kasich AM
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):292-306. PubMed ID: 5247
    [No Abstract]   [Full Text] [Related]  

  • 36. A multiclinic double-blind trial of the anxiolytic properties of lorazepam in psychiatric outpatient practice [proceedings].
    Lipman R; Vanov SK; Richards DJ
    Psychopharmacol Bull; 1977 Apr; 13(2):17-9. PubMed ID: 16308
    [No Abstract]   [Full Text] [Related]  

  • 37. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
    Griffiths RR; Johnson MW; Carducci MA; Umbricht A; Richards WA; Richards BD; Cosimano MP; Klinedinst MA
    J Psychopharmacol; 2016 Dec; 30(12):1181-1197. PubMed ID: 27909165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.
    Kraehenmann R; Preller KH; Scheidegger M; Pokorny T; Bosch OG; Seifritz E; Vollenweider FX
    Biol Psychiatry; 2015 Oct; 78(8):572-81. PubMed ID: 24882567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.
    Studerus E; Kometer M; Hasler F; Vollenweider FX
    J Psychopharmacol; 2011 Nov; 25(11):1434-52. PubMed ID: 20855349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
    Diamond BI; Nguyen H; O'Neal E; Ochs R; Kaffeman M; Borison RL
    Psychopharmacol Bull; 1991; 27(1):67-71. PubMed ID: 1677774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.